In late July 2026 an FDA advisory committee then recommended six peptides including BPC-157, TB-500, KPV, and MOTS-c for the compounding list
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review
Yes, our BPC-157 products are third-party tested for purity, quality and consistency
Within research settings, BPC-157 is widely studied in relation to: Recovery of muscles, tendons and ligaments Supporting wound healing and skin repair Protection and restoration of the digestive tract Regulation of inflammatory processes Joint and connective tissue support Recovery from physical strain or injury Because of this broad research focus, BPC-157 has become one of the most researched peptides within the field of regenerative science
In line with this, acute toxicology showed that BPC 157 even at a very high dose (2 g/kg) had no signs of toxic or lethal effects (30, 34-36)
GLP-Squared is $289/mo month-to-month (or $249/mo on the 3-month plan) and eliminates the need for multiple injections while addressing both GLP-1 and GIP receptor pathways for broader appetite and metabolic effects